Shepherd Financial Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,673
Closed -$815K 224
2024
Q2
$815K Buy
1,673
+2
+0.1% +$1K 0.11% 110
2024
Q1
$902K Buy
1,671
+60
+4% +$32.8K 0.12% 105
2023
Q4
$894K Sell
1,611
-14
-0.9% -$6.57K 0.13% 103
2023
Q3
$711K Buy
1,625
+69
+4% +$34.4K 0.11% 108
2023
Q2
$781K Sell
1,556
-7
-0.4% -$3.35K 0.12% 104
2023
Q1
$782K Buy
1,563
+292
+23% +$140K 0.13% 101
2022
Q4
$519K Buy
1,271
+620
+95% +$241K 0.09% 118
2022
Q3
$212K Buy
+651
New +$239K 0.04% 157

Other funds holding IDXX

Shepherd Financial Partners's IDXX Position: Q3 2024 in Review

Shepherd Financial Partners sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 1,673 shares — an estimated $815K sold.

Shepherd Financial Partners first reported a position in IDXX in Q3 2022 and held it in 8 quarters. The position peaked at $902K in Q1 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Shepherd Financial Partners reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Shepherd Financial Partners sold 1,673 Idexx Laboratories shares in Q3 2024, an estimated $815K.
  • Shepherd Financial Partners first reported a position in Idexx Laboratories in Q3 2022 and held it in 8 quarters.
  • Shepherd Financial Partners's Idexx Laboratories position peaked at $902K in Q1 2024.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Shepherd Financial Partners's 13F filing for Q3 2024, filed 28 Oct 2024.